Susan R. Salka - Jan 10, 2022 Form 4 Insider Report for AMN HEALTHCARE SERVICES INC (AMN)

Role
Chief Executive Officer, Director
Signature
/s/ Susan R. Salka
Stock symbol
AMN
Transactions as of
Jan 10, 2022
Transactions value $
-$1,566,361
Form type
4
Date filed
1/12/2022, 08:28 PM
Previous filing
Jan 6, 2022
Next filing
Jan 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMN Common Stock Sale -$167K -1.59K -4.65% $105.06 32.6K Jan 10, 2022 Direct F1, F2
transaction AMN Common Stock Sale -$149K -1.4K -4.3% $106.58 31.2K Jan 10, 2022 Direct F3, F4
transaction AMN Common Stock Sale -$215K -2K -6.42% $107.65 29.2K Jan 10, 2022 Direct F5, F6
transaction AMN Common Stock Sale -$229K -2.1K -7.2% $108.92 27.1K Jan 10, 2022 Direct F7, F8
transaction AMN Common Stock Sale -$209K -1.9K -7.02% $109.90 25.2K Jan 10, 2022 Direct F9, F10
transaction AMN Common Stock Sale -$133K -1.2K -4.77% $111.02 24K Jan 10, 2022 Direct F11, F12
transaction AMN Common Stock Sale -$281K -2.51K -10.47% $112.10 21.5K Jan 10, 2022 Direct F13, F14
transaction AMN Common Stock Sale -$149K -1.32K -6.13% $113.21 20.1K Jan 10, 2022 Direct F15, F16
transaction AMN Common Stock Sale -$33.9K -295 -1.46% $114.92 19.8K Jan 10, 2022 Direct F17, F18
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of 1,588 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in this row represents a weighted average price of $105.0633 per share. These shares were sold in multiple transactions at prices ranging from $104.82 to $105.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 The sale of 1,400 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F4 The price reported in this row represents a weighted average price of $106.5838 per share. These shares were sold in multiple transactions at prices ranging from $106.09 to $106.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F5 The sale of 2,000 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F6 The price reported in this row represents a weighted average price of $107.64625 per share. These shares were sold in multiple transactions at prices ranging from $107.26 to $108.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F7 The sale of 2,100 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F8 The price reported in this row represents a weighted average price of $108.91607 per share. These shares were sold in multiple transactions at prices ranging from $108.42 to $109.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F9 The sale of 1,900 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F10 The price reported in this row represents a weighted average price of $109.8985 per share. These shares were sold in multiple transactions at prices ranging from $109.60 to $110.275, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F11 The sale of 1,200 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F12 The price reported in this row represents a weighted average price of $111.01875 per share. These shares were sold in multiple transactions at prices ranging from $110.61 to $111.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F13 The sale of 2,510 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F14 The price reported in this row represents a weighted average price of $112.10 per share. These shares were sold in multiple transactions at prices ranging from $111.64 to $112.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F15 The sale of 1,316 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F16 The price reported in this row represents a weighted average price of $113.2104 per share. These shares were sold in multiple transactions at prices ranging from $112.97 to $113.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F17 The sale of 295 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F18 The number of shares reflected in this column does not include 101,243 vested Restricted Stock Units that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.